Artrite idiopatica giovanile
Revisione paritaria di Dr Rosalyn Adleman, MRCGPUltimo aggiornamento di Dr Doug McKechnie, MRCGPUltimo aggiornamento 9 Apr 2025
Rispetta le linee guida editoriali
- ScaricaScarica
- Condividi
- Language
- Discussione
- Versione audio
- Aggiungi alle fonti preferite su Google
In questa serie:Artrite reumatoideFarmaci antireumatici modificanti la malattiaMedicinali biologici per l'artrite reumatoide
L'artrite idiopatica giovanile è una condizione in cui l'infiammazione persistente delle articolazioni si manifesta per la prima volta nei bambini sotto i 16 anni. Le articolazioni colpite diventano dolorose e gonfie, e possono danneggiarsi. L'artrite idiopatica giovanile generalmente non può essere curata, ma esistono trattamenti efficaci. Questi aiutano a ridurre i sintomi, prevenire problemi articolari a lungo termine e possono portare alla remissione.
A colpo d'occhio
Juvenile idiopathic arthritis (JIA) is joint inflammation in children under 16 years old, lasting at least six weeks.
It causes joint pain and swelling, often worse in the morning, and can affect other parts of the body.
There are seven types of JIA, with varied symptoms, such as oligoarticular JIA affecting 1-4 joints.
Diagnosis involves looking at symptoms, a physical exam, blood tests, and scans like X-rays or MRI.
Treatments aim to relieve symptoms, prevent joint damage, and achieve remission, but not usually a cure.
Physiotherapy, medicines such as NSAIDs, steroids, and DMARDs, and sometimes surgery, are used.
Untreated JIA can lead to growth problems, weak bones, delayed puberty, and eye inflammation.
What is juvenile idiopathic arthritis?
Juvenile means it affects young people. Idiopatica means the cause is not known. Artrite means inflammation of one or more joints. The main symptoms of arthritis are pain and stiffness of affected joints. The stiffness is usually worse first thing in the morning, or after resting. The inflammation causes swelling around the affected joints.
So, juvenile idiopathic arthritis (JIA) is a condition in which this inflammation of one or more joints begins in children under the age of 16 years. It lasts for at least six weeks. In most people who get JIA, it is a long-term illness. It can be treated, but not usually cured - in other words, symptoms can be relieved, and joint damage can be prevented, but symptoms may return in future.
Juvenile idiopathic arthritis causes
JIA is an autoimmune condition, where the body's immune system attacks its own cells and tissues.
We don't know exactly why this happens in people with JIA. It's thought that some people may have a set of different genes that make them vulnerable to developing JIA, and that something in the environment can then trigger the disease to begin.
Juvenile idiopathic arthritis types
There are seven different types of JIA. The symptoms vary depending on the type of JIA:
Oligoarticular JIA. This type accounts for at least half of all cases of JIA in Europe and the USA. Arthritis affects between 1 and 4 joints during the first six months after the arthritis begins. One of the blood tests taken may show a positive result for antinuclear antibodies. Antinuclear antibodies are a type of protein in the blood, called auto-antibodies. These proteins occur in people with some conditions and can be measured in the blood. See the separate leaflet called Antibody and antigen tests for more details.
Extended oligoarthritis. If more than six joints are affected after six months, it is called extended oligoarthritis.
Persistent oligoarthritis. If no more than four joints are affected after six months then it is called persistent oligoarthritis.
Polyarticular JIA - rheumatoid factor negative. This type accounts for another quarter of all cases of JIA. Arthritis affects five or more joints in the first six months. A blood test for a chemical called rheumatoid factor (RF) in the blood is negative.
Polyarticular JIA - RF positive. Arthritis affects five or more joints in the first six months. A blood test for RF in the blood is positive. This is the type in about 5 in 100 cases of JIA.
Systemic-onset JIA. This is the type in 5-10 out of every 100 cases of JIA. Arthritis develops with at least two weeks of daily high temperature (fever). The fever must be greater than 39ºC and return to less than 37ºC between the episodes of fever. There must be one or more of:
A rash which quickly fades and changes.
Increased size of lymph nodes.
Increased size of the liver and/or spleen.
Inflammation of the lining of the heart (pericarditis), lungs (pleuritis) or the abdomen (peritonitis).
Juvenile psoriatic arthritis. This type is involved in 2-15 out of every 100 cases of JIA. Arthritis occurs with a skin condition called psoriasis or there is arthritis plus at least two of:
Inflammation of a finger or toe, causing pain and swelling.
Abnormality of one or more fingernails.
Psoriasis in a close relative.
Enthesitis-related arthritis. This is the type in 2-10 out of every 100 cases of JIA. Arthritis occurs with inflammation where ligaments or tendons attach to the bone (called enthesitis), plus any two of:
Pain in the joints of the lower back (lumbosacral spine) and/or the pelvis (sacroiliac joints).
A blood test for a chemical marker of certain diseases - called HLA B27 - is positive in 90% of people who have enthesitis-related JIA.
A family history of illnesses associated with being HLA B27-positive, including ankylosing spondylitis, inflammation affecting the eye (uveite), artrite psoriasica e colite ulcerosa.
The child affected with enthesitis-related arthritis also has other illnesses associated with being positive for HLA B27.
The arthritis affects a boy and starts when the boy is over the age of 6 years.
Undifferentiated arthritis. Undifferentiated JIA is used to describe arthritis that doesn't fit into any of the other different groups of JIA. About 1-10 of every 100 cases fit into this category.
How common is juvenile idiopathic arthritis?
Juvenile idiopathic arthritis (JIA) is uncommon, although it is the most common type of arthritis that affects children. Between 1 and 2 in every 1,000 children are affected at any one time. Between 1 and 2 in every 10,000 children develop JIA each year.
How common each type is varies in different parts of the world. For example, in the UK, oligoarticular JIA is the most common type. Polyarticular JIA is more common in countries such as India, New Zealand and South Africa. Systemic arthritis is more common in Asia than it is in Europe.
Juvenile idiopathic arthritis symptoms
The main symptom of juvenile idiopathic arthritis (JIA) is:
Pain and swelling of several joints (arthritis).
Sometimes, other symptoms outside of joints (known as extra-articular symptoms) may also be present. These include conditions causing:
Eye inflammation (uveitis).
Inflammation of the lining of the heart (pericarditis), lungs (pleuritis) or abdomen (peritonitis).
JIA may also in some cases be associated with high temperature (fever) or symptoms of anaemia (such as feeling tired all the time).
In very young children, it may be harder to know they have joint pain.
They may cry more than usual or wake up crying.
They may have delayed crawling or walking, or may become less mobile than they were before.
They may lose weight or be just generally miserable and not right.
You may notice that joints are hot or swollen or red.
Older children may be able to describe the stiffness or pain they have in one or more joints.
The symptoms are slightly different depending on the type of JIA:
Oligoarticular JIA symptoms
This usually presents in children under 6 years old and is more common in girls. It often starts with one or two swollen joints causing stiffness and reduced movement but often not much pain. The knees and ankles are most often affected.
Polyarticular JIA (RF negative) symptoms
This most often presents in preschool children and in children aged 10-13 years. It is more common in girls.
Polyarticular JIA (RF positive) symptoms
Gonfiore. This affects small joints, especially the joints of both hands and wrists, with swelling and stiffness.
Lumps. Rheumatoid nodules may develop. These are small painless lumps which occur on the skin over the elbows and forearms.
Infiammazione. There may also be fever, an increase in the size of the liver, spleen and glands, and inflammation of the lining of the heart, lungs or abdomen.
Systemic JIA symptoms
This usually starts before the age of 5 years.
Febbre. A high fever often occurs, most often in the afternoon or evening, with a rapid return of the temperature to normal. The fever comes daily for at least 2 weeks.
Eruzione cutanea. A rash often appears with the fever. The rash is usually a light pink colour and quickly disappears.
Artrite. Arthritis only occurs at the start of the disease in about one third of children but usually develops within a few months. The arthritis usually affects several joints.
Juvenile psoriatic arthritis symptoms
This affects girls twice as often as boys and tends to start at about 6 years of age. The arthritis affects both small and large joints. In over half of affected children, the arthritis starts before the psoriasis.
Enthesitis-related JIA symptoms
This affects boys much more often than girls and usually starts after 10 years of age. It often affects the legs and may cause pain in the heel. There is often swelling of a knee or foot. Psoriasis, eye inflammation and bowel inflammation may also occur with enthesitis-related JIA.
How is juvenile idiopathic arthritis diagnosed?
The diagnosis of juvenile idiopathic arthritis (JIA) is based on the symptoms and an examination by your doctor. Tests are important. They help to:
Find out what type of arthritis it is.
Make sure there are no other causes for the symptoms, such as infections, bone infection or a break (fracture) of a bone.
Blood tests include a test for anemia (which may occur with JIA) and tests for inflammation (called ESR and CRP, which are often raised with JIA). Blood tests may also be useful to see whether any infection (virus or bacteria) has caused the arthritis and not JIA.
Other blood tests are used to see if there is a positive test for chemicals which are markers for different types of inflammation. Examples of these markers are called antinuclear antibodies, RF and HLA B27.
Other tests include the following:
radiografie, which are normal in the early stages of JIA but help to check for any other bone or joint problems such as infection or injury.
Ultrasound scans to see if there is any fluid in the joint and the extent of arthritis of the joint.
Scansioni di risonanza magnetica (MRI) to show details of the damage to the joint and any changes of the bones surrounding the joints.
If there is any possibility of an infection in a joint then some fluid may be taken from the joint and sent to the laboratory for testing.
Juvenile idiopathic arthritis treatment
The aims of treatment are to help the symptoms and reduce damage to joints. The other aim is to put the disease into remission. Doctors don't usually talk about 'curing' juvenile idiopathic arthritis (JIA), but they try to make the disease no longer active so there is no inflammation in any joint, and so there are no symptoms. This is called remission. It can last for months, for years, or in some cases can be lifelong.
Trattamenti fisici
Physiotherapy and occupational therapy are used to help keep the affected joints working as normally as possible. They also reduce the risk of any permanent damage to the joints. Hydrotherapy (which involves different methods of treatment using water) can also be very helpful. Children should be encouraged to participate in as much physical activity as possible, including most sports and dancing. Moist heat can help to relieve pain, and in some cases shoe inserts (orthotics) can be useful.
Surgery may be needed in some cases where joint damage is severe, including joint replacement operations.
Medicinali
Farmaci antinfiammatori non steroidei (FANS) can be used to help reduce pain and stiffness in the joints. Commonly used NSAIDs include ibuprofene, naprossene, indometacina e diclofenac. NSAIDs help to relieve symptoms but do not affect the progression of the disease.
Steroids help to settle inflammation and may be used in different ways:
Steroid tablets may be needed to improve the symptom relief and when the disease affects other parts of the body, such as the lining of the heart (pericarditis), lungs (pleuritis) and abdomen (peritonitis).
Steroid eye drops or creams may be needed for eye inflammation.
Disease-modifying antirheumatic drugs (DMARDs) may be used to help reduce the effects of the disease. These medicines can be very effective but also need very close supervision by your specialist doctor. DMARDs used for JIA include:
Biological medicines are another group of medicines used by specialists to help symptoms and reduce joint damage. These newer treatment options have improved outlook for people who don't respond to the other treatments. As they are relatively new medicines, there are still studies being done to establish whether there are any long-term health risks from taking them. Options include:
Tocilizumab
Infliximab
Abatacept
Adalimumab
Tofacitinib is another new drug. It belongs to a type of drug called JAK kinase inhibitors. It is sometimes used if certain biologic medications haven't worked, or aren't suitable.
What are the complications of juvenile idiopathic arthritis?
Without treatment, juvenile idiopathic arthritis (JIA) can lead to problems with growth, weakness of bones (osteoporosis) and a delay of puberty.
There may be long-term problems with the affected joints.
Some children who develop inflammation affecting the eye (uveite) may have long-term reduced vision.
They also have an increased risk of later developing cataracts oppure aumento della pressione oculare (glaucoma).
Because they are unable to participate in all the usual physical activities with friends and at school, children with JIA may have emotional and behavioural difficulties and problems at school. This can be made worse because of having to deal with pain and the amount of time taken away from school in order to attend hospital appointments and admissions. Therefore, children with JIA and their families often need a lot of support.
Qual è la prospettiva (prognosi)?
With modern treatments, the outlook for most children with juvenile idiopathic arthritis (JIA) is now very good. However, the outlook is variable depending on the type and the severity of JIA. It is important for the diagnosis to be made early and treatment to be started early.
JIA is a serious disease because it can cause a lot of pain and can cause disability if joint damage is not prevented with early treatment. However, treatment can often stop disability and damage, and it is not life-threatening.
JIA is a long-term condition for most people who have it. Often the treatment results in remission, so that there are no symptoms and the joints have no inflammation. However, if symptoms return, further treatment may be needed. Remission can last for weeks, months, years or even be lifelong. Because it is not usually possible to predict for sure in advance how long remission will last, doctors don't usually use the word 'cured'. Instead they will usually talk about 'remission'. Depending on your type of JIA, however, your specialist may be able to give you a reasonable idea about your individual outlook and how long remission is likely to last.
Most children with JIA, having had treatment, have inactive disease within two years. That is, they have no symptoms and no inflamed joints. Many do not need to continue on treatment.
When children get too grown up for the children and adolescents' specialist (usually at age 16-18), they will be transferred to the care of an adult joint specialist (rheumatologist).
Comprendere le articolazioni
The place where two bones meet is called a joint. Joints allow movement and flexibility of various parts of the body. The movement of the bones is caused by muscles which pull on tendons that are attached to bone. Cartilage covers the end of bones. Between the cartilage of two bones that form a joint there is a small amount of thick fluid called synovial fluid. This lubricates the joint, which allows smooth movement between the bones.
Articolazione normale

© Patient.info
The synovium is the tissue that surrounds a joint. Synovial fluid is made by cells of the synovium. The outer part of the synovium is called the capsule. This is tough, gives the joint stability and stops the bones from moving out of joint. Surrounding ligaments and muscles also help to give support and stability to joints.
See the separate leaflet called Joint pain for more general information about pain in joints. The separate leaflet on Arthritis may also be helpful.
Scelte del paziente per Sviluppo

Salute dei bambini
Epifisi scivolata della testa femorale
Una epifisi femorale capitale scivolata si verifica quando l'epifisi superiore, o capitale, dell'osso della coscia (femore) scivola lateralmente fuori dall'estremità del femore. (L'epifisi è la parte terminale del femore. C'è un'epifisi a ciascuna estremità.) Colpisce più comunemente ragazzi più grandi e adolescenti che sono in sovrappeso. Il dolore all'anca o al ginocchio e lo zoppicare sono i sintomi principali. Può essere diagnosticata con una radiografia. Il trattamento di solito comporta un intervento chirurgico per impedire all'epifisi di muoversi. Se il tuo bambino ha sintomi che suggeriscono questa condizione, dovrebbe vedere il medico prontamente.
di Dr Jacqueline Payne, FRCGP

Salute dei bambini
Piede torto
Piede torto (anche chiamato talipes equinovarus) è una deformità del piede e della caviglia con cui un bambino può nascere. Non è chiaro esattamente cosa causi il piede torto. Nella maggior parte dei casi, viene diagnosticato dall'aspetto tipico del piede di un neonato dopo la nascita. Il metodo Ponseti è un trattamento ampiamente utilizzato per il piede torto. Questo trattamento dà buoni risultati per la maggior parte dei bambini. Se non funziona, la chirurgia può aiutare.
di Dr Doug McKechnie, MRCGP
Domande frequenti
Can juvenile idiopathic arthritis be cured permanently?
While doctors do not typically use the word 'cured' for juvenile idiopathic arthritis (JIA), the goal of treatment is to achieve remission. Remission means the disease is no longer active, there's no inflammation in any joint, and there are no symptoms. This state can last for months, years, or even a lifetime, but symptoms may return in the future. Treatment aims to manage symptoms and prevent joint damage.
What is the typical age range for children to be diagnosed with juvenile idiopathic arthritis?
Juvenile idiopathic arthritis (JIA) is a condition that begins in children under the age of 16 years. Specific types of JIA tend to present at different ages; for example, oligoarticular JIA usually affects children under 6 years old, while systemic JIA often starts before age 5. Enthesitis-related JIA typically begins after 10 years of age.
Are there emotional or social difficulties associated with juvenile idiopathic arthritis?
Yes, children with juvenile idiopathic arthritis (JIA) may experience emotional and behavioural difficulties. This can be due to not being able to participate in physical activities with friends and at school, dealing with chronic pain, and having to miss school for hospital appointments and admissions. Children with JIA and their families often require significant support to cope with these challenges.
What happens when a child with juvenile idiopathic arthritis becomes an adult?
When children with juvenile idiopathic arthritis (JIA) outgrow the care of a children's and adolescents' specialist, usually between the ages of 16 and 18, they will be transferred to the care of an adult joint specialist, known as a rheumatologist. This transition ensures continued management of their condition.
What are 'biological medicines' used for juvenile idiopathic arthritis?
Biological medicines are a newer group of treatments prescribed by specialists to help manage symptoms and reduce joint damage in juvenile idiopathic arthritis (JIA). These options are often considered for people who haven't responded well to other treatments. Examples include Etanercept, Tocilizumab, Infliximab, Abatacept, and Adalimumab. Research is ongoing to understand their long-term health risks.
Ulteriori letture e riferimenti
- Stoll ML, Cron RQ; Treatment of juvenile idiopathic arthritis: a revolution in care. Pediatr Rheumatol Online J. 2014 Apr 23;12:13. doi: 10.1186/1546-0096-12-13. eCollection 2014.
- Beukelman T; Treatment advances in systemic juvenile idiopathic arthritis. F1000Prime Rep. 2014 Apr 1;6:21. doi: 10.12703/P6-21. eCollection 2014.
- Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis; Linee guida per la valutazione tecnologica NICE, dicembre 2015
- Giancane G, Consolaro A, Lanni S, et al; Juvenile Idiopathic Arthritis: Diagnosis and Treatment. Rheumatol Ther. 2016 Dec;3(2):187-207. doi: 10.1007/s40744-016-0040-4. Epub 2016 Aug 12.
- Davies K, Cleary G, Foster H, et al; BSPAR Standards of Care for children and young people with juvenile idiopathic arthritis. Rheumatology (Oxford). 2010 Jul;49(7):1406-8. doi: 10.1093/rheumatology/kep460. Epub 2010 Feb 19.
- Tofacitinib for treating juvenile idiopathic arthritis; NICE Technology appraisal guidance, October 2021
Informazioni sull'autoreVisualizza il profilo completo

Dr Doug McKechnie, MRCGP
Scrittore Medico
MA, MBBS, MSc, DRCOG, MRCP(UK), MRCGP(2021), FHEA
Il dottor Doug McKechnie è un medico di base del NHS che lavora a Londra. Lavora a tempo pieno in ambito clinico ed è anche Vice Responsabile del modulo di Pratica Clinica e Professionale presso la Scuola di Medicina dell'University College London.
Informazioni sul recensoreVisualizza il profilo completo

Dr Rosalyn Adleman, MRCGP
MRCGP
La Dott.ssa Rosalyn Adleman è un medico di base del NHS che lavora nel nord di Londra.
Storia dell'articolo
Le informazioni su questa pagina sono scritte e revisionate da clinici qualificati.
Articolo disponibile anche in Inglese, Tedesco, Spagnolo, Francese, Italiano, Portoghese, Hindi, Ebraico, Arabo, and Svedese.
Prossima revisione prevista: 8 Apr 2028
9 Apr 2025 | Ultima versione

Chiedi, condividi, connettiti.
Esplora le discussioni, fai domande e condividi esperienze su centinaia di argomenti di salute.

Non ti senti bene?
Valuta i tuoi sintomi online gratuitamente
Iscriviti alla newsletter di Patient
La tua dose settimanale di consigli sulla salute chiari e affidabili - scritti per aiutarti a sentirti informato, sicuro e in controllo.
Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.
Di più sulla salute dei bambini
- Albinismo
- Allarmi per pipì a letto
- Leucemie infantili
- Coliche nei neonati e nei lattanti
- Croup
- Displasia evolutiva dell'anca
- Sindrome di Down
- distrofia muscolare di Duchenne
- Malattia di Kawasaki
- Sindrome di Marfan
- Meningite
- Parotite
- Dermatite da pannolino
- Strabismo nei bambini
- Sindrome di Turner
- Testicoli ritenuti
- Infezione urinaria nei bambini
- Pertosse
- la malattia di Wilson